Eli Lilly's 15-minute chart triggers RSI overbought, Bollinger Bands narrowing.

Eli Lilly's 15-minute chart has triggered an RSI Overbought signal, along with narrowing Bollinger Bands, as of July 18, 2025, at 10:30. This suggests that the stock price has risen too rapidly and exceeds the fundamental support level, while the magnitude of stock price fluctuations is decreasing.

Eli Lilly and Company (LLY) stock has triggered an RSI Overbought signal and narrowing Bollinger Bands on its 15-minute chart as of July 18, 2025, at 10:30. This technical indicator suggests that the stock price has risen too rapidly and may be exceeding its fundamental support level. Additionally, the narrowing Bollinger Bands indicate a decrease in the magnitude of stock price fluctuations, which can signal a potential reversal in price momentum.

The stock price fell by -3.58% on Thursday, July 17, 2025, from $789.80 to $761.50, with a day low at $760.02 and a day high at $789.92. Over the last 10 days, the stock has risen in 7 out of 10 days but is still down by -2.28% for the period. The volume increased by 318 thousand shares on the last day, which may indicate an early warning of increased risk [1].

Eli Lilly's stock is currently within a very wide and falling short-term trend, with expectations of a further decline of -3.65% over the next three months. The stock is predicted to hold a price between $668.63 and $838.12 at the end of this period [1].

The stock holds several negative signals, including sell signals from both short and long-term moving averages. Corrections up may face resistance at $784.71 and $777.61. A break-up above these levels could issue buy signals, but a sell signal was issued from a pivot top point on June 13, 2025, with a fall of -7.06% since then. A sell signal is also present from the 3-month Moving Average Convergence Divergence (MACD) [1].

Eli Lilly finds support at $755.57, which may hold a buying opportunity. The stock has shown very controlled movements and low risk due to good liquidity. The daily average volatility for the last week was 3.26% [1].

For the upcoming trading day on Friday, July 18, 2025, the stock is expected to open at $770.48 and move between $751.12 and $771.88, with a possible trading interval of +/-$20.76 (+/-2.76%) from the last closing price. The risk/reward intra-day is seen as attractive, with the stock closer to support than resistance [1].

Eli Lilly's weight loss drug Zepbound underperformed in sales in the third quarter, raising concerns about the weight loss drug market. However, Novo Nordisk's Wegovy reassured investors with strong sales growth. The weight loss drug market is predicted to reach a size of $100 billion by the end of this decade [2].

References:
[1] https://stockinvest.us/stock/LLY
[2] https://www.moomoo.com/news/post/87420085/record-tr4cking-news-default